<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>the akampioneer &#187; biosimilars</title>
	<atom:link href="http://akampioneer.com/tag/biosimilars/feed" rel="self" type="application/rss+xml" />
	<link>http://akampioneer.com</link>
	<description></description>
	<lastBuildDate>Mon, 14 May 2012 08:00:40 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
		<item>
		<title>Food for Thought: The Indian Biotechnology Industry &#8211; Opportunities for Europe</title>
		<link>http://akampioneer.com/food-for-thought/food-for-thought-the-indian-biotechnology-industry-opportunities-for-europe.html</link>
		<comments>http://akampioneer.com/food-for-thought/food-for-thought-the-indian-biotechnology-industry-opportunities-for-europe.html#comments</comments>
		<pubDate>Tue, 28 Feb 2012 08:55:15 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Food for Thought]]></category>
		<category><![CDATA[Amal Mukhopadhyay]]></category>
		<category><![CDATA[Association of Biotechnology Led Enterprises]]></category>
		<category><![CDATA[bioinformatics]]></category>
		<category><![CDATA[biosimilars]]></category>
		<category><![CDATA[Biospectrum]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[ELGA Biotech]]></category>
		<category><![CDATA[IGEP Foundation]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indo-German Chamber of Commerce]]></category>
		<category><![CDATA[manufacturing]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=2242</guid>
		<description><![CDATA[By Dr. Amal Mukhopadhyay The Indian biotechnology industry is growing at record speed, both in terms of turnover and investments. While Indian biotech is recognized in the West  for high quality services, bioinformatics and manufacturing, it also offers great opportunities for conducting clinical trials and manufacturing of biosimilars. Only recently, European companies have started to [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/food-for-thought/food-for-thought-the-indian-biotechnology-industry-opportunities-for-europe.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Food for Thought: The Future of Biosimilars</title>
		<link>http://akampioneer.com/food-for-thought/food-for-thought-the-future-of-biosimilars.html</link>
		<comments>http://akampioneer.com/food-for-thought/food-for-thought-the-future-of-biosimilars.html#comments</comments>
		<pubDate>Fri, 11 Jun 2010 13:10:51 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Food for Thought]]></category>
		<category><![CDATA[Adem Koyuncu]]></category>
		<category><![CDATA[biosimilars]]></category>
		<category><![CDATA[Christopher Klein]]></category>
		<category><![CDATA[dvfa]]></category>
		<category><![CDATA[EMEA]]></category>
		<category><![CDATA[Falk Ehmann]]></category>
		<category><![CDATA[Frank Pieters]]></category>
		<category><![CDATA[Gertraud Unterrainer]]></category>
		<category><![CDATA[LSP Life Science Partners]]></category>
		<category><![CDATA[Manfred Ruediger]]></category>
		<category><![CDATA[Mayer Brown LLP]]></category>
		<category><![CDATA[ProBioGen]]></category>
		<category><![CDATA[Sandoz]]></category>
		<category><![CDATA[Society of Investment Professionals in Germany]]></category>
		<category><![CDATA[Teva Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=420</guid>
		<description><![CDATA[On June 8, the Society of Investment Professionals in Germany (DVFA) and its Life Science Committee hosted its annual conference which this time focused on biosimilars. The event covered key scientific topics, regulatory pathways and commercial issues of the market. While experts agreed that the US will soon follow the EU in establishing a regulatory [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/food-for-thought/food-for-thought-the-future-of-biosimilars.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

